首页 > 市场调查报告书 > 医疗设备

体外诊断

败血症诊断市场规模、份额和成长分析（按技术、应用、产品、方法、病原体类型、检测类型、最终用户和地区划分）—2026-2033年产业预测

市场调查报告书

商品编码

1899574

败血症诊断市场规模、份额和成长分析（按技术、应用、产品、方法、病原体类型、检测类型、最终用户和地区划分）—2026-2033年产业预测

Sepsis Diagnostics Market Size, Share, and Growth Analysis, By Technology (Blood Culture Technology), By Application, By Product, By Method, By Pathogen Type, By Test Type, By End Users, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月25日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，败血症诊断市场规模将达到 7.5 亿美元，到 2025 年将达到 8.2 亿美元，到 2033 年将达到 15.9 亿美元，在预测期（2026-2033 年）内复合年增长率为 8.7%。

败血症诊断市场是医疗保健领域的重要组成部分，其重点在于识别和管理败血症，主要驱动因素是感染疾病导致的住院人数不断上升，尤其是在老年人和免疫力缺乏等弱势群体中。多重检测和快速PCR检测等技术进步显着提高了检测的准确性和速度。医疗机构的支持性管理方案和指南也进一步推动了市场成长。然而，挑战依然存在，例如先进诊断检测的高成本限制了资源匮乏地区的可及性，以及诊断的复杂性可能导致延误和误诊。此外，检测通讯协定的差异性也会阻碍创新技术的应用。儘管如此，生物标记开发、快速检测解决方案以及机器学习和人工智慧在诊断领域的应用仍有许多机会。

败血症诊断市场驱动因素

全球败血症诊断市场的主要驱动因素是败血症盛行率的不断上升，败血症通常与高死亡率和巨大的医疗成本有关。医疗专业人员对早期诊断和治疗的认识不断提高，推动了对能够快速识别败血症的先进诊断工具的需求。此外，抗生素抗药性的日益严重以及人口老化导致感染疾病风险增加，也加剧了对有效败血症管理解决方案的需求。这些因素共同推动了脓毒症诊断技术的创新和投资，进一步促进了市场成长。

限制败血症诊断市场的因素

由于败血症相关症状广泛且特异性，早期诊断十分困难，因此败血症诊断市场面临严峻挑战。这种复杂性可能导致治疗延误和误诊，最终降低诊断工具的有效性。此外，准确诊断脓毒症通常需要结合多种检测方法，这进一步增加了诊断过程的复杂性，并延长了结果报告时间。这些因素阻碍了市场成长，因为它们可能导致医疗成本增加，并最终影响患者的治疗效果。脓毒症的复杂性给临床医生和诊断公司都带来了挑战。

脓毒症诊断市场趋势

败血症诊断市场正经历强劲成长，主要得益于分子诊断技术的进步，尤其是次世代定序(NGS) 和聚合酵素链锁反应(PCR) 技术的应用。这些创新方法能够快速且准确地识别病原体，与传统培养方法相比，显着缩短了诊断时间。这种快速检测能力对于及时干预脓毒症治疗至关重要，最终有助于改善患者预后。对早期诊断和个人化医疗的日益重视进一步推动了对这些先进诊断解决方案的需求，使其在全球医疗机构的败血症管理策略中占据核心地位。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

BioMerieux SA（France）
Becton, Dickinson and Company（BD）（USA）
Thermo Fisher Scientific, Inc.（USA）
F. Hoffmann-La Roche AG（Switzerland）
Danaher Corporation（Beckman Coulter, Inc.）（USA）
Bruker Corporation（USA）
Abbott Laboratories, Inc.（USA）
Cepheid（USA）
Luminex Corporation（USA）
T2 Biosystems, Inc.（USA）
Siemens Healthineers（Germany）
Qiagen NV（Netherlands）
Immunexpress, Inc.（USA）
Seegene Inc.（South Korea）
Koninklijke Philips NV（Netherlands）
GenMark Diagnostics（USA）
Wolters Kluwer NV.（Netherlands）
Epic Systems Corporation.（USA）
McKesson Corporation.（USA）

结论与建议

简介目录

Product Code: SQMIG35A2237

Sepsis Diagnostics Market size was valued at USD 0.75 Billion in 2024 and is poised to grow from USD 0.82 Billion in 2025 to USD 1.59 Billion by 2033, growing at a CAGR of 8.7% during the forecast period (2026-2033).

The sepsis diagnostics market is a crucial component of healthcare focused on identifying and managing sepsis, primarily driven by increased hospitalizations due to infections among vulnerable populations, such as the elderly and immunocompromised individuals. Technological advancements, including multiplex assays and rapid PCR tests, significantly enhance detection accuracy and speed. Supportive regulatory initiatives and guidelines from healthcare organizations further stimulate market growth. However, challenges persist, such as high costs of advanced diagnostic tests limiting accessibility in resource-constrained settings, and complexities in diagnosis leading to potential delays or misdiagnoses. Additionally, fluctuating testing protocols can hinder the adoption of innovative technologies. Nonetheless, opportunities abound in the development of biomarkers, rapid testing solutions, and the integration of machine learning and artificial intelligence in diagnostics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Sepsis Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Sepsis Diagnostics Market Segments Analysis

Global Sepsis Diagnostics Market is segmented by Technology, Application, Product, Method, Pathogen Type, Test Type, End Users and region. Based on Technology, the market is segmented into Blood Culture Technology. Based on Application, the market is segmented into Hospitals and Diagnostics Centres. Based on Product, the market is segmented into Blood Culture Media, Assays and Reagent Kits, Instruments and Software. Based on Method, the market is segmented into Conventional Diagnostics and Automated Diagnostics. Based on Pathogen Type, the market is segmented into Bacterial Sepsis and Other Pathogen Types. Based on Test Type, the market is segmented into Laboratory Tests andPoint-Of-Care Tests. Based on End Users, the market is segmented into Hospitals And Speciality Clinics, Pathology and Reference Laboratories, Research Laboratories and Academic Institute. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Sepsis Diagnostics Market

A key market driver for the global sepsis diagnostics market is the increasing prevalence of sepsis, which is often associated with high mortality rates and significant healthcare costs. The growing awareness among healthcare professionals regarding early diagnosis and treatment is fostering the demand for advanced diagnostic tools that can swiftly identify septic conditions. Furthermore, the rise in antibiotic resistance and the expanding aging population, who are more susceptible to infections, have amplified the need for effective sepsis management solutions. This convergence of factors is propelling innovation and investment in sepsis diagnostic technologies, further enhancing market growth.

Restraints in the Sepsis Diagnostics Market

The sepsis diagnostics market faces significant challenges due to the wide array of non-specific symptoms associated with sepsis, making early diagnosis complicated. This complexity can lead to delays in treatment or misdiagnosis, ultimately diminishing the effectiveness of diagnostic tools. Additionally, accurately diagnosing sepsis often requires a combination of various tests, which further complicates the diagnostic process and extends result turnaround times. These factors collectively hinder market growth, as they can lead to increased healthcare costs and ultimately impact patient outcomes. The intricate nature of sepsis complicates the landscape for both clinicians and diagnostic companies alike.

Market Trends of the Sepsis Diagnostics Market

The Sepsis Diagnostics market is witnessing a robust trend towards advancements in molecular diagnostics, particularly through the adoption of next-generation sequencing (NGS) and polymerase chain reaction (PCR) technologies. These innovative methods facilitate rapid and precise pathogen identification, drastically minimizing the time required for diagnosis compared to traditional culture techniques. This swift detection capability is crucial for timely intervention in sepsis treatment, ultimately improving patient outcomes. The growing focus on early diagnosis and personalized medicine is further driving the demand for these advanced diagnostic solutions, positioning them at the forefront of sepsis management strategies in healthcare settings globally.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Sepsis Diagnostics Market Size by Technology & CAGR (2026-2033)

Market Overview
Blood Culture Technology

Global Sepsis Diagnostics Market Size by Application & CAGR (2026-2033)

Market Overview
Hospitals
Diagnostics Centres

Global Sepsis Diagnostics Market Size by Product & CAGR (2026-2033)

Market Overview
Blood Culture Media
Assays and Reagent Kits
Instruments
Software

Global Sepsis Diagnostics Market Size by Method & CAGR (2026-2033)

Market Overview
Conventional Diagnostics
Automated Diagnostics

Global Sepsis Diagnostics Market Size by Pathogen Type & CAGR (2026-2033)

Market Overview
Bacterial Sepsis
- Gram-Negative Bacterial Sepsis
- Gram-Positive Bacterial Sepsis Fungal Sepsis
Other Pathogen Types

Global Sepsis Diagnostics Market Size by Test Type & CAGR (2026-2033)

Market Overview
Laboratory Tests
Point-Of-Care Tests

Global Sepsis Diagnostics Market Size by End Users & CAGR (2026-2033)

Market Overview
Hospitals And Speciality Clinics
Pathology and Reference Laboratories
Research Laboratories
Academic Institute

Global Sepsis Diagnostics Market Size & CAGR (2026-2033)

North America (Technology, Application, Product, Method, Pathogen Type, Test Type, End Users)
- US
- Canada
Europe (Technology, Application, Product, Method, Pathogen Type, Test Type, End Users)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Technology, Application, Product, Method, Pathogen Type, Test Type, End Users)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Technology, Application, Product, Method, Pathogen Type, Test Type, End Users)
- Brazil
- Rest of Latin America
Middle East & Africa (Technology, Application, Product, Method, Pathogen Type, Test Type, End Users)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

BioMerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (Beckman Coulter, Inc.) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bruker Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cepheid (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Luminex Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
T2 Biosystems, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Immunexpress, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Seegene Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenMark Diagnostics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wolters Kluwer NV. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Epic Systems Corporation. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
McKesson Corporation. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments